Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
With the CDC's ACIP sidelined, major medical societies have independently released flu, COVID-19, and RSV vaccine recommendations for the upcoming respiratory season. But publishing guidance is just step one — clinicians now face the harder task of countering misinformation and having trusted, evidence-based conversations with patients. In a climate of growing vaccine skepticism, every healthcare touchpoint matters.
With the CDC's Advisory Committee on Immunization Practices (ACIP) effectively sidelined — its reconstituted members stayed by a federal judge in March 2026 — leading medical societies including the AAP, AAFP, ACOG, and IDSA have stepped in to fill the void. Coordinating with the AMA's Vaccine Integrity Project, they released independent recommendations for flu, COVID-19, and RSV immunization ahead of the fall respiratory season, finding no new safety concerns and affirming that vaccines continue to reduce severe disease and hospitalization.
But the policy vacuum isn't the only challenge. Mixed messages from federal leaders are fueling patient confusion that clinicians must now navigate directly. The AMA has launched SpreadTheFacts.org to consolidate guidance and resources, and insurers have signaled they'll cover fall immunizations.
Key Takeaways:
Why it matters: In the absence of a functioning federal immunization infrastructure, the burden of vaccine communication falls squarely on frontline healthcare workers. Trusted clinician conversations may be the most powerful public health tool this respiratory season.
